TGFB1 and myalgic encephalomeyelitis/chronic fatigue syndrome: In conclusion, our results suggest that HBI‐8000 improves HFpEF by blocking the TGF‐β1/MAPK signalling pathway and inhibiting the proliferation and transformation of CFs as well as the excessive deposition of ECM.